
1. int j infect dis. 2019 aug;85:49-53. doi: 10.1016/j.ijid.2019.04.035. epub 2019
may 9.

distribution cytochrome p450 cyp2c8*2 allele brazzaville, republic of
congo.

peko sm(1), ntoumi f(2), vouvoungui c(3), nderu d(4), kobawila sc(5), velavan
tp(6), koukouikila-koussounda f(7).

author information: 
(1)fondation congolaise pour la recherche médicale (fcrm), brazzaville, republic 
of congo; faculty sciences technology, university marien ngouabi,
brazzaville, republic congo. electronic address: simonmarie88peko@gmail.com.
(2)fondation congolaise pour la recherche médicale (fcrm), brazzaville, republic 
of congo; faculty sciences technology, university marien ngouabi,
brazzaville, republic congo; institute tropical medicine, university of
tübingen, tübingen, germany. electronic address: ffntoumi@hotmail.com.
(3)fondation congolaise pour la recherche médicale (fcrm), brazzaville, republic 
of congo; faculty sciences technology, university marien ngouabi,
brazzaville, republic congo. electronic address: vjchristevy@gmail.com.
(4)institute tropical medicine, university tübingen, tübingen, germany.
electronic address: dnderu@gmail.com.
(5)faculty sciences technology, university marien ngouabi, brazzaville,
republic congo. electronic address: kobawila.simon@gmail.com.
(6)fondation congolaise pour la recherche médicale (fcrm), brazzaville, republic 
of congo; institute tropical medicine, university tübingen, tübingen,
germany; faculty medicine, duy tan university, da nang, vietnam. electronic
address: velavan@medizin.uni-tuebingen.de.
(7)fondation congolaise pour la recherche médicale (fcrm), brazzaville, republic 
of congo; faculty sciences technology, university marien ngouabi,
brazzaville, republic congo. electronic address: felixkoukouikila@yahoo.fr.

background: cytochrome p450 (cyp) enzymes essential metabolism most
drugs used today. single nucleotide polymorphism(s) occurring cyp genes can
adversely affect drug pharmacokinetics, efficacy, safety. individuals
carrying cyp2c8*2 c.805a > t (cyp2c8*2; rs11572103) allele impaired
amodiaquine metabolism, increased risk amodiaquine-related adverse events, and
may promote selection drug-resistant parasite strains. study
investigated distribution cyp2c8*2 allele brazzaville, republic 
congo, artesunate + amodiaquine used second-line treatment for
uncomplicated plasmodium falciparum malaria.
methods: total 285 febrile children visiting marien ngouabi paediatric
hospital genotyped cyp2c8*2 using pcr-restriction fragment length
polymorphism (pcr-rflp). allele frequencies genotype distribution were
determined.
results: cyp2c8*2 allele successfully genotyped 75% (213/285) the
study participants. cyp2c8*2a allele frequency 63%, whereas the
cyp2c8*2t allele frequency 37%. genotypes cyp2c8*2aa (rapid
metabolizer), cyp2c8*2at (intermediate metabolizer), cyp2c8*2tt (poor
metabolizer) observed 44%, 38%, 18% investigated participants,
respectively.
conclusions: study gives first description cyp2c8*2 allele
distribution republic congo highlights potential risk of
amodiaquine-related adverse events. information study be
beneficial pharmacovigilance investigations.

copyright © 2019. published elsevier ltd.

doi: 10.1016/j.ijid.2019.04.035 
pmid: 31078747  [indexed medline]

